1
|
Yang K, Wu J, Li S, Wang S, Zhang J, Wang YP, Yan YS, Hu HY, Xiong MF, Bai CB, Sun YQ, Chen WQ, Zeng Y, Yuan JL, Yin CH. NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathway. Cell Death Discov 2023; 9:404. [PMID: 37907480 PMCID: PMC10618268 DOI: 10.1038/s41420-023-01685-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 10/03/2023] [Accepted: 10/13/2023] [Indexed: 11/02/2023] Open
Abstract
Hippocampal neuronal damage may induce cognitive impairment. Neurotrophic tyrosine kinase receptor 1 (NTRK1) reportedly regulates neuronal damage, although the underlying mechanism remains unclear. The present study aimed to investigate the role of NTRK1 in mouse hippocampal neuronal damage and the specific mechanism. A mouse NTRK1-knockdown model was established and subjected to pre-treatment with BAY-3827, followed by a behavioral test, Nissl staining, and NeuN immunofluorescence (IF) staining to evaluate the cognitive impairment and hippocampal neuronal damage. Next, an in vitro analysis was conducted using the CCK-8 assay, TUNEL assay, NeuN IF staining, DCFH-DA staining, JC-1 staining, ATP content test, mRFP-eGFP-LC3 assay, and LC3-II IF staining to elucidate the effect of NTRK1 on mouse hippocampal neuronal activity, apoptosis, damage, mitochondrial function, and autophagy. Subsequently, rescue experiments were performed by subjecting the NTRK1-knockdown neurons to pre-treatment with O304 and Rapamycin. The AMPK/ULK1/FUNDC1 pathway activity and mitophagy were detected using western blotting (WB) analysis. Resultantly, in vivo analysis revealed that NTRK1 knockdown induced mouse cognitive impairment and hippocampal tissue damage, in addition to inactivating the AMPK/ULK1/FUNDC1 pathway activity and mitophagy in the hippocampal tissues of mice. The treatment with BAY-3827 exacerbated the mouse depressive-like behavior induced by NTRK1 knockdown. The results of in vitro analysis indicated that NTRK1 knockdown attenuated viability, NeuN expression, ATP production, mitochondrial membrane potential, and mitophagy, while enhancing apoptosis and ROS production in mouse hippocampal neurons. Conversely, pre-treatment with O304 and rapamycin abrogated the suppression of mitophagy and the promotion of neuronal damage induced upon NTRK1 silencing. Conclusively, NTRK1 knockdown induces mouse hippocampal neuronal damage through the suppression of mitophagy via inactivating the AMPK/ULK1/FUNDC1 pathway. This finding would provide insight leading to the development of novel strategies for the treatment of cognitive impairment induced due to hippocampal neuronal damage.
Collapse
Affiliation(s)
- Kai Yang
- Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital; Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China
| | - Jue Wu
- Medical Innovation Research Division, Chinese PLA General Hospital, Beijing, 100853, China
| | - Shang Li
- Department of Anesthesiology, Peking University People's Hospital, Beijing, 100044, China
| | - Shan Wang
- Medical Innovation Research Division, Chinese PLA General Hospital, Beijing, 100853, China
| | - Jing Zhang
- Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Key Laboratory of Maternal and Fetal Medicine of Hebei Province, Shijiazhuang, Hebei, 050011, China
| | - Yi-Peng Wang
- Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital; Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China
| | - You-Sheng Yan
- Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital; Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China
| | - Hua-Ying Hu
- Medical Innovation Research Division, Chinese PLA General Hospital, Beijing, 100853, China
| | - Ming-Fang Xiong
- Institute of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China
| | - Chao-Bo Bai
- Department of Neurology, Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, 100191, China
| | - Yong-Qing Sun
- Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital; Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China
| | - Wen-Qi Chen
- Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Key Laboratory of Maternal and Fetal Medicine of Hebei Province, Shijiazhuang, Hebei, 050011, China
| | - Yang Zeng
- Institute of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.
| | - Jun-Liang Yuan
- Department of Neurology, Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, 100191, China.
| | - Cheng-Hong Yin
- Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital; Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, 100026, China.
| |
Collapse
|
2
|
Shi X, Zhang Q, Chang M, Zhang Y, Zhao M, Yang B, Li P, Zhang Y. Ferroptosis is involved in passive Heymann nephritis in rats. Heliyon 2023; 9:e21050. [PMID: 37886789 PMCID: PMC10597846 DOI: 10.1016/j.heliyon.2023.e21050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Revised: 10/04/2023] [Accepted: 10/13/2023] [Indexed: 10/28/2023] Open
Abstract
Ferroptosis is found to be involved in some experimental models of kidney diseases, but its role in membrane nephropathy (MN) is still unclear. The purpose of this study is to explore whether ferroptosis occurred in MN, and the role of ferritinophagy. In this study, passive Heymann nephritis (PHN) rats were induced by single tail vein injection of anti-Fx1A serum, and normal rats were used as control. The changes of 24 h urinary protein, serum biochemical parameters, renal pathological damage, iron content, lipid peroxidation parameters, ferroptosis markers, and ferritinophagy markers were evaluated in the two groups. Compared with the control group, PHN rats showed obvious proteinuria, hypoproteinemia, and hyperlipidemia. Besides, more severe renal pathological damage and higher Fe2+ levels were observed in PHN rats, and the levels of malondialdehyde (MDA) increased significantly, while the levels of superoxide Dismutase (SOD) and glutathione (GSH) decreased. In addition, the expression of glutathione peroxidase 4 (GPX4) in renal tissues of PHN rats decreased significantly, while the expression of transferrin receptor (TFR) and acyl-CoA synthetase long-chain family member 4 (ACSL4) increased. The expression of microtubule associated protein 1 light chain 3 (LC3) II/LC3I and nuclear receptor coactivator 4 (NCOA4) increased significantly. Therefore, our study shows that ferroptosis is involved in the pathological damage of MN, and companied by activation of ferritinophagy.
Collapse
Affiliation(s)
- Xiujie Shi
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Qi Zhang
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Meiying Chang
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Yifan Zhang
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
- Beijing University of Chinese Medicine, Beijing, 100029, China
| | - MingMing Zhao
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Bin Yang
- Department of Pathology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Peng Li
- Experimental Research Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
| | - Yu Zhang
- Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China
- Xin-Huangpu Joint Innovation Institute of Chinese Medicine, Guangzhou, 510535, China
| |
Collapse
|
3
|
Li Q, Xu M, Zhang Z, Yin M, Zhang Y, Liu F. Urinary exosomal hsa_circ_0001250 as a novel diagnostic biomarker of idiopathic membranous nephropathy. J Transl Med 2022; 20:607. [PMID: 36536378 PMCID: PMC9761943 DOI: 10.1186/s12967-022-03784-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 11/21/2022] [Indexed: 12/23/2022] Open
Abstract
AIMS Idiopathic membranous nephropathy (IMN) is a common cause of adult nephrotic syndrome. Currently, the diagnosis of IMN mainly depends on renal biopsy, which is invasive. What's more, markers already known for the clinical diagnosis of IMN are not sensitive enough. The present study aims to investigate the profiling of urinary exosomal circular RNAs (circRNAs) of IMN, and to look for a potential biomarker for diagnosis of IMN. METHODS Urine exosomes were collected from patients with IMN and idiopathic nephrotic syndrome (INS), as well as healthy controls (HCs) by ultracentrifuge. A pairwise comparison between 5 IMN and 5 HC was performed by high-throughput sequencing. Enrichment analysis were performed to explore the potential functions of differentially expressed circRNAs in IMN. Among three differentially expressed circRNAs which may be involved in signaling pathways of pathogenesis of IMN and matched conserved mouse circRNAs, hsa_circ_0001250 was selected as the target circRNA after quantitative polymerase chain reaction among 23 IMN, 19 INS and 23HC. Sanger sequencing and RNase R digestion assay were performed to validated the ring-structure and sequence of hsa_circ_0001250. ROC (Receiver Operating Characteristic) curve correlation analysis was used to further validate the potential utility of hsa_circ_0001250 as a diagnostic biomarker of IMN. A circRNA-miRNA-mRNA network was constructed to reflect the relationship between hsa_circ_0001250 and its target miRNAs and mRNAs. RESULTS 766 up-regulated and 283 down-regulated circRNAs were identified in IMN patients. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed signaling pathways of pathogenesis of IMN which the different expressed circRNAs may participate in. The ring-structure and the sequence of hsa_circ_0001250 were confirmed, the expression of hsa_circ_0001250 was validated significantly increased in IMN, relevant with high level of proteinuria. A circRNA-miRNA-mRNA network reflected that hsa_circ_0001250 may play a role in the pathogenesis of IMN by target hsa-miR-639 and hsa-miR-4449. CONCLUSION We revealed the expression and functional profile of differentially expressed urinary exosomal circRNAs of IMN patients. Urinary exosomal hsa_circ_0001250 was tested as a potential biomarker of IMN and a predicted circRNA-miRNA-mRNA network was constructed.
Collapse
Affiliation(s)
- Qianyu Li
- grid.415954.80000 0004 1771 3349Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| | - Mingzhu Xu
- grid.415954.80000 0004 1771 3349Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| | - Zhiping Zhang
- grid.415954.80000 0004 1771 3349Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| | - Min Yin
- grid.415954.80000 0004 1771 3349Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| | - Yucheng Zhang
- grid.415954.80000 0004 1771 3349Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| | - Feng Liu
- grid.415954.80000 0004 1771 3349Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin China
| |
Collapse
|
4
|
Sun Y, Yuan C, Yu J, Zhu C, Wei X, Yin J. Plant-derived bisbenzylisoquinoline alkaloid tetrandrine prevents human podocyte injury by regulating the miR-150-5p/NPHS1 axis. OPEN CHEM 2022. [DOI: 10.1515/chem-2022-0259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Abstract
Podocytes have become a crucial target for kidney disease. Tetrandrine (TET), the main active component of a Chinese medicine formula Fangji Huangqi Tang, has shown a positive effect on various renal diseases. We aimed to investigate the effect and mechanism of TET on podocytes. The targeting relationship between microRNA (miR)-150-5p and nephrosis 1 (NPHS1) was determined by a dual-luciferase reporter gene assay. Cell proliferation, migration, and apoptosis were detected by cell counting kit-8, Transwell, and flow cytometry assays, respectively. The expression of miR-150-5p and NPHS1 was detected by RT-qPCR. The levels of Nephrin, Caspase-3, Bcl-2, Bax, E-cadherin, and α-smooth muscle actin were detected by Western blot. TET prompted cell viability and inhibited migration and apoptosis of puromycin aminonucleoside-induced human podocytes (HPC) in a dose-dependent manner. miR-150-5p directly targeted NPHS1 and was upregulated in damaged HPC. TET decreased the miR-150-5p expression and increased the level of NPHS1 and Nephrin. Overexpressed miR-150-5p inhibited the expression of NPHS1 and Nephrin, and reversed the protective effects of TET on injured HPC. TET protects the biological function of HPC by suppressing the miR-150-5p/NPHS1 axis. It reveals that TET may be a potential drug and miR150-5p is a potential therapeutic target for the treatment of podocyte injury.
Collapse
Affiliation(s)
- Yue Sun
- Department of Nephropathy, Key Laboratory of Kidney Disease Prevention and Control Technology of Zhejiang Province, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , No. 453 Stadium Road , Hangzhou 310007 , Zhejiang , China
| | - Chenyi Yuan
- Department of Nephropathy, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , Hangzhou 310007 , Zhejiang , China
| | - Jin Yu
- Department of Nephropathy, Key Laboratory of Kidney Disease Prevention and Control Technology of Zhejiang Province, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , No. 453 Stadium Road , Hangzhou 310007 , Zhejiang , China
| | - Caifeng Zhu
- Department of Nephropathy, Key Laboratory of Kidney Disease Prevention and Control Technology of Zhejiang Province, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , No. 453 Stadium Road , Hangzhou 310007 , Zhejiang , China
| | - Xia Wei
- Department of Digestive, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , Hangzhou 310007 , Zhejiang , China
| | - Jiazhen Yin
- Department of Nephropathy, Key Laboratory of Kidney Disease Prevention and Control Technology of Zhejiang Province, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine) , No. 453 Stadium Road , Hangzhou 310007 , Zhejiang , China
| |
Collapse
|
5
|
Shang J, Zhang Y, Guo R, Liu W, Zhang J, Yan G, Wu F, Cui W, Wang P, Zheng X, Wang T, Dong Y, Zhao J, Wang L, Xiao J, Zhao Z. Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2022; 9:e2201581. [PMID: 35975460 PMCID: PMC9534961 DOI: 10.1002/advs.202201581] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 07/06/2022] [Indexed: 05/15/2023]
Abstract
Membranous nephropathy (MN) is a common cause of nephrotic syndrome. The aim is to establish a non-invasive diagnostic model of MN using differential gut microbiome analysis, and to explore the relationship between the gut microbiome and MN pathogenesis in vivo. 825 fecal samples from MN patients and healthy participants are collected from multiple medical centers across China. Key operational taxonomic units (OTUs) obtained through 16S rRNA sequencing are used to establish a diagnostic model. A rat model of MN is developed to explore the relationship between the gut microbiome and the pathogenesis of MN. The diversity and richness of the gut microbiome are significantly lower in patients with MN than in healthy individuals. The diagnostic model based on seven OTUs achieves an excellent efficiency of 98.36% in the training group and also achieves high efficiency in cross-regional cohorts. In MN rat model, gut microbiome elimination prevents model establishment, but fecal microbiome transplantation restores the phenotype of protein urine. Gut microbiome analysis can be used as a non-invasive tool for MN diagnosis. The onset of MN depends on the presence of naturally colonized microbiome. Early intervention in the gut microbiome may help reduce urinary protein level in MN.
Collapse
Affiliation(s)
- Jin Shang
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
- Laboratory Animal Platform of Academy of Medical SciencesZhengzhou UniversityZhengzhouHenan450000P. R. China
- Laboratory of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052P. R. China
| | - Yiding Zhang
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Ruixue Guo
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Wenli Liu
- Department of Clinical LaboratoryPeking Union Medical College HospitalPeking Union Medical College & China Academy of Medical ScienceBeijing100730China
| | - Jun Zhang
- Department of Nephrologythe Third Affiliated Hospital of Sun Yat‐Sen UniversityGuangzhouGuangdong510630China
| | - Ge Yan
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Feng Wu
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Wen Cui
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Peipei Wang
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Xuejun Zheng
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Ting Wang
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Yijun Dong
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Jing Zhao
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
| | - Li Wang
- Biobank of The First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052P. R. China
| | - Jing Xiao
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
- Laboratory of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052P. R. China
| | - Zhanzheng Zhao
- Department of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052China
- Zhengzhou UniversityZhengzhouHenan450000P. R. China
- Laboratory Animal Platform of Academy of Medical SciencesZhengzhou UniversityZhengzhouHenan450000P. R. China
- Laboratory of NephrologyThe First Affiliated Hospital of Zhengzhou UniversityZhengzhouHenan450052P. R. China
| |
Collapse
|